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the different regions of Germany. In 
contrast, within these particular geo-
graphic areas, only slight sequence 
differences were found in longitudi-
nal analysis over several years. This 
conclusion is supported by the novel 
human Waldkirchen sequence (H72), 
which is almost identical to the BF 
strains from 2004 (6,10) and the 
similarity of newly derived human 
sequences from Munsterland (H208, 
H303) to the Berkel strain from 1994 
(7). The molecular characterization 
of the viral sequences of patient and 
rodent origin from the outbreak areas 
demonstrates that PUUV is the caus-
ative agent of the current outbreak.
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Chikungunya 
Virus in Aedes 
albopictus, Italy  
To the Editor: Chikungunya vi-
rus (CHIKV) infection is a self-lim-
iting illness characterized by fever, 
headache, weakness, rash, and arth-
ralgia. Some patients show prolonged 
weakness or arthralgia lasting several 
months. In 2006, several Indian Ocean 
states and India experienced outbreaks 
of CHIKV infection, where the vector 
was postulated to be Aedes albopictus 
in at least some areas (1,2). 
Starting from mid July 2007, in 2 
villages in Ravenna Province in Italy, 
Castiglione di Ravenna (≈1,700 in-
habitants) and Castiglione di Cervia 
(≈2,000 inhabitants), several residents 
sought treatment at local hospitals 
and health centers for high fever and 
arthralgia, joint and muscular pain, 
severe headaches, body aches, and in 
some cases, rash. Since the beginning 
of August 2007, an increasing num-
ber of febrile syndromes associated 
with arthralgia have been recorded 
among the residents of the area. By 
the end of August, the number of sick 
persons had increased to ≈150 (3). 
At the beginning of September, the 
disease was confi rmed as chikungu-
nya fever by the Superior Institute of 
Health (4).
On August 21 and 22, 2007, an 
entomologic investigation was carried 
out in the area. Ae. albopictus (215 
females and 57 males), Culex pipiens 
(369 females and 15 males), and a few 
specimens of Ae. caspius (5 females) 
and Anopheles spp. (2 females) were 
collected by using 3 light traps with-
out CO2 (Centers for Disease Control 
and Prevention [CDC], Atlanta, GA, 
USA) and 8 CO2-baited traps (similar 
to the CDC light trap) activated once 
overnight. Collections were obtained 
by using 2 small-handled aspirators 
per day of sampling. Collected mos-
quitoes were divided by species and 
pooled as described in the Table. 
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Each pool was analyzed for 
CHIKV or nucleic acid (viral isolation 
and CHIKV-specifi c reverse transcrip-
tion–PCR [RT-PCR]). Total RNA was 
extracted from supernatant of mosqui-
toes homogenized in minimal essential 
medium by using TRIzol LS (Invitro-
gen, Carlsbad, CA USA), and cDNA 
was synthesized by using SuperScript 
II (Invitrogen) and random primers. 
Two PCR protocols were used on the 
same samples: a nested RT-PCR (5) 
and a real-time PCR (6). Positive re-
sults were obtained from samples 1 
and 2 (Table) with both PCR proto-
cols. No positive control was avail-
able to the authors at the time of the 
fi rst PCR-positive detection of virus 
from mosquitoes; therefore, labora-
tory contamination can be excluded. 
Moreover, from the same PCR-posi-
tive samples of Ae. albopictus (Table), 
viral isolation was achieved. 
The 172-bp PCR fragment ob-
tained after the second round of the 
nested RT-PCR (5) was located in the 
E2 gene between nt positions 9486 and 
9660 according to nucleotide sequence 
of the S27 strain genome (GenBank 
accession no. AF369024). The se-
quence of this fragment was obtained 
by using a BigDye Terminator Cycle 
Sequencing kit (Applied Biosystems, 
Foster City, CA, USA) and compared 
with the available CHIKV sequences, 
including Indian isolates obtained dur-
ing 2005–2006 (IND-06), the earlier 
Indian isolates (1963 and 1973), the 
isolate from Yawat in 2000, Reunion 
isolates during 2005–2006 (RU), the 
Senegal strain (1983), and the S27 and 
Ross isolates (1952). The sequence of 
the isolate from Italy is clustered into 
the Central/East African genotype and 
showed highest nucleotide identity 
(99.4%–100.0%) with isolates from 
IND-06 and 100% identity at the 
amino acid level with isolates from 
IND-06 and from RU. These results 
must be considered carefully because 
the short-sequenced fragment does not 
enable confi rmation of the epidemio-
logic origin of the isolate from Italy. 
The sequence of the whole genome 
of CHIKV isolates from mosquitoes 
in Italy is an ongoing process; when 
completed, results will be available in 
GenBank. 
The remainder of insect samples, 
which included a few male samples of 
Ae. albopictus, generated PCR-nega-
tive results with both protocols tested. 
Male mosquitoes were tested to detect 
evidence of transovarian transmission, 
but the small number of mosquitoes 
tested suggests possible vertical trans-
mission of the virus in the Italian out-
break. Chikungunya fever in Italy has 
been reported recently by Beltrame et 
al. (7) but those cases involved 9 pa-
tients who were infected while trav-
eling in regions where CHIKV was 
endemic. 
In spite of the large diffusion of 
Ae. albopictus in Italy recorded since 
1990 and broadly distributed all over 
the country (8), this outbreak of Chi-
kungunya fever is evidence of an ac-
tive endogenous circulation of the 
virus and could represent a possible 
introduction of this disease in Italy. 
No prediction can be made about 
spread and persistence of the virus in 
Italy because the vector is now pres-
ent in all areas of the country and re-
cent winters have been characterized 
by mild temperatures. Most likely, 
because transovarial infection has not 
been demonstrated for CHIKV, spread 
of infection will remain limited. How-
ever, as this report documents, Italy is 
at risk for infection with arboviruses, 
such as dengue virus and West Nile 
virus, which have serious effects on 
public health. 
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Table. Pooled mosquito samples analyzed for chikungunya virus, Italy 
Pool No. mosquitoes Sex Species Site of collection PCR results
1 125  F Aedes albopictus Castiglione Ravenna  Positive
2 90  F Ae. albopictus Castiglione Cervia  Positive
3 214  F Culex pipiens Castiglione Ravenna  Negative
4 155  F Cx. pipiens Castiglione Cervia Negative
5 5  F Ae. caspius Castiglione Ravenna and Castiglione Cervia  Negative
6 2  F Anopheles spp. Castiglione Ravenna and Castiglione Cervia  Negative
7 57  M Ae. albopictus Castiglione Ravenna and Castiglione Cervia Negative
8 15  M Cx. pipiens Castiglione Ravenna and Castiglione Cervia Negative
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Persistent Human 
Metapneumovirus 
Infection in 
Immunocom-
promised Child 
To the Editor: Respiratory vi-
ral infections can be associated with 
a wide range of clinical manifesta-
tions from self-limiting upper respira-
tory tract diseases to pneumonia (1). 
However, in general, respiratory viral 
infections are more likely to progress 
to more severe diseases in immmu-
nocompromised patients. Human 
metapneumovirus (hMPV) has been 
reported in most parts of the world as 
a cause of acute respiratory tract in-
fections in persons of all age groups 
(2). Fatal hMPV infections have been 
reported in immunocompromised pa-
tients, including a 17-month-old girl 
who had acute lymphoblastic leuke-
mia (3) and a 33-year-old woman who 
had received a hematopoietic stem 
cell transplant (HSCT) (4). In adult 
HSCT recipients, fatal pneumonia (5) 
and persistent hMPV infection with-
out respiratory symptoms have been 
described (6). In addition, adult lung 
transplant recipients have been able 
to clear hMPV infection despite high 
levels of immunosuppression (7). We 
report a case of persistent hMPV infec-
tion in a child with severe combined 
immunodefi ciency disorder (SCID) 
who shed hMPV during an 11-month 
period.
The child, a girl who was born in 
January 2002, received an allogeneic 
haploidentical stem cell transplant 
from her father in May 2002 after 
her diagnosis of SCID. Infection with 
infl uenza A virus (H3N2) was diag-
nosed on April 2005 and progressed 
to a chronic pneumonitis of the lin-
gula. She received successive courses 
of anti-infl uenza agents (amantadine, 
oseltamivir, and zanamivir) for 1 year 
during which time several positive 
infl uenza cultures were obtained (8). 
Four years after the transplant, she 
was still lymphopenic (800 × 109/L, 
mostly T cells) and had chronic graft-
versus-host disease, which had been 
treated with steroids (prednisone 2.5 
mg twice a day for many months). She 
also had a mild chronic cough but did 
not need supplemental oxygen while 
she was receiving nebulized zana-
mivir (10–20 mg twice a day). Her 2 
nasopharyngeal aspirate (NPA) speci-
mens from June and July 2006 were 
negative for infl uenza virus. However, 
positive cultures for hMPV were ob-
tained from NPA and bronchoalveolar 
lavage specimens collected on July 
2006. After receiving this result, we 
performed retrospective and prospec-
tive molecular detection studies for 
hMPV for this patient. HMPV was de-
tected by reverse transcription–PCR 
for the F and G genes (9) in 6 and 7 
NPA samples, respectively, collected 
during an 11-month period from No-
vember 4, 2005, through October 4, 
2006. These samples were obtained 
for surveillance of infl uenza infection 
in this child with persistent cough.
Amplifi ed hMPV G sequences 
were aligned by using the Clustal
W program (www.molecularevolution.
org/cdc/software/clustalw). A phylo
genetic tree was constructed with 
MEGA 3.1 software (www.megasoft
ware.net) by using the neighbor-
joining algorithm with Kimura-2 
parameters. Sequence analysis of the 
hMPV G gene showed that all strains 
belonged to the B2 genotype, which 
clustered with hMPV Can98–75 and 
NL1/94 reference strains (Figure, 
panel A). Amplifi ed hMPV G gene 
sequences of the 6 samples collected 
in 2006 were identical, but they had 
96.7% and 92.8% nucleotide and 
amino acid identities, respectively, 
with the initial strain from November 
2005, which clearly indicates 2 viral 
strains (Figure, panel B). Similar re-
sults were obtained with the F gene 
(data not shown). Inoculation of the 
respiratory samples on a panel of 10 
cell lines as previously described (10) 
showed that only 2 of 7 NPA samples 
were positive for hMPV by culture; 
2 of the 5 remaining samples were 
positive for infl uenza A, which may 
have masked the cytopathic effects 
of hMPV on rhesus monkey kidney 
(LLC-MK2) cells.
Persistent hMPV infection in 
asymptomatic adult HSCT recipients 
has been described (6). In that study, 
hMPV was isolated from 2 patients in 
2 consecutive samples collected 12–56 
days apart. However, virus evolution 
was not adequately investigated be-
cause it was based on sequence anal-
ysis of a 150-bp fragment from the 
highly conserved nucleoprotein gene 
(6). Unlike in previous reports (6,7), 
characterization of hMPV strains in 
our study was performed by sequence 
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